Identification of translational dermatology research priorities in the U.K.: Results of an electronic Delphi exercise

British Journal of Dermatology

Volumn 173, Issue 5, 2015, Pages 1191-1198

  Healy, E ^a,b   Brown, S J ^c,d   Langan, S M ^e   Nicholls, S G ^f   Shams, K ^g   Reynolds, N J ^h,i  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b ROYAL SOUTH HANTS HOSPITAL   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d UNIVERSITY OF DUNDEE   (United Kingdom)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f UNIVERSITY OF OTTAWA   (Canada)

^g UNIVERSITY OF GLASGOW   (United Kingdom)

^h NEWCASTLE UNIVERSITY   (United Kingdom)

ⁱ ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; DELPHI STUDY; DERMATITIS; DRUG HYPERSENSITIVITY; ECZEMA; ELECTRONIC DELPHI EXERCISE; EXERCISE; HUMAN; LICHEN PLANUS; MELANOMA; PATHOGENESIS; PRIORITY JOURNAL; PSORIASIS; RESEARCH PRIORITY; SKIN CANCER; SKIN DISEASE; SQUAMOUS CELL CARCINOMA; SUPPORT GROUP; SUPPURATIVE HIDRADENITIS; TOXIC EPIDERMAL NECROLYSIS; TRANSLATIONAL RESEARCH; UNITED KINGDOM; DERMATOLOGY; INTERNET; RESEARCH; SKIN DISEASES;

DELPHI TECHNIQUE; DERMATOLOGY; HUMANS; INTERNET; RESEARCH; SKIN DISEASES; TRANSLATIONAL MEDICAL RESEARCH; UNITED KINGDOM;

EID: 84983095482     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.14022     Document Type: Article

References (41)

1. Burns DA, Cox NH,. Introduction and historical bibliography. In: Rook's Textbook of Dermatology (, Burns T, Breathnack S, Cox N, Griffiths C, eds), 8th edn. Oxford: Wiley-Blackwell, 2010; 1-10
2. Schofield JK, Grindlay D, Williams HC,. Skin Conditions in the UK: A Health Care Needs Assessment. Centre of Evidence Based Dermatology, University of Nottingham, UK: Metro Commercial Printing Ltd, 2009.
3. Nestle FO, Kaplan DH, Barker J,. Psoriasis. N Engl J Med 2009; 361: 496-509.
4. Wadonda-Kabondo N, Sterne JAC, Golding J, et al,. A prospective study of the prevalence and incidence of atopic dermatitis in children aged 0-42 months. Br J Dermatol 2003; 149: 1023-8.
5. Bhate K, Williams HC,. Epidemiology of acne vulgaris. Br J Dermatol 2013; 168: 474-85.
6. Cancer Research UK. Data Table: Cancer incidence and mortality rates in the UK. Available at: http://publications.cancerresearchuk.org/cancerstats/statsreports/dtincmortrates.html (last accessed 28 September 2015).
7. Lucas R, McMichael T, Smith W, Armstrong B,. Solar Ultraviolet Radiation: Global Burden of Disease from Solar Ultraviolet Radiation. Environmental Burden of Disease Series, No. 13. Geneva: World Health Organization, 2006.
8. Basra MK, Fenech R, Gatt RM, et al,. The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol 2008; 159: 997-1035.
9. Basra MK, Sue-Ho R, Finlay AY,. The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease. Br J Dermatol 2007; 156: 528-38.
10. Hay RJ, Johns NE, Williams HC, et al,. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol 2014; 134: 1527-34.
11. NHS England. NHS England Research and Development Strategy Consultation. Available at: http://www.england.nhs.uk/ourwork/gov/research-dev-strategy/ (last accessed 28 September 2015).
12. UK TREND. UK Translational Research Network in Dermatology. Available at: http://www.uktrend.org/home/4587271444 (last accessed 28 September 2015).
13. Linstone HA, Turoff M, (eds). The Delphi Method: Techniques and Applications. Reading, MA: Addison-Wesley, 1975.
14. Bolger F, Rowe G,. Delphi: somewhere between Scylla and Charybdis? Proc Natl Acad Sci U S A 2014; 111: E4284.
15. Dalkey N, Helmer O,. An experimental application of the Delphi method to the use of experts. Manag Sci 1963; 9: 458-67.
16. Kesselheim AS, Avorn J,. The most transformative drugs of the past 25 years: a survey of physicians. Nat Rev Drug Discov 2013; 12: 425-31.
17. Wisniowski A, Bijak J, Shang HL,. Forecasting Scottish migration in the context of 2014 constitutional change debate. Popul Space Place 2014; 20: 455-64.
18. Harder A, Place NT, Scheer SD,. Towards a competency-based extension education curriculum: a Delphi study. J Agric Educ 2010; 51: 44-52.
19. Porta M, Mas-Machuca M, Martinez-Costa C, et al,. A Delphi study on Technology Enhanced Learning (TEL) applied on Computer Science (CS) skills. Int J Educ Dev Inform Comm Tech 2012; 8: 46-70.
20. Clayton R, Perera R, Burge S,. Defining the dermatological content of the undergraduate medical curriculum: a modified Delphi study. Br J Dermatol 2006; 155: 137-44.
21. Harrington JM,. Research priorities in occupational medicine: a survey of United Kingdom medical opinion by the Delphi technique. Occup Environ Med 1994; 51: 289-94.
22. Sheikh A, Major P, Holgate ST,. Developing consensus on national respiratory research priorities: key findings from the UK Respiratory Research Collaborative's e-Delphi exercise. Respir Med 2008; 102: 1089-92.
23. Collins PY, Patel V, Joestl SS, et al,. Grand challenges in global mental health. Nature 2011; 475: 27-30.
24. Nicholls SG, Wilson BJ, Castle D, et al,. Personalized medicine and genome-based treatments: why personalized medicine ≠ individualized treatments. Clin Ethics 2014; 9: 135-44.
25. Khoury MJ, Gwinn ML, Glasgow RE, Kramer BS,. A population approach to precision medicine. Am J Prev Med 2012; 42: 639-45.
26. Pendergrass SA, Lemaire R, Francis IP, et al,. Intrinsic gene expression subsets of diffuse cutaneous systemic sclerosis are stable in serial skin biopsies. J Invest Dermatol 2012; 132: 1363-73.
27. Schmitt J, Rosumeck S, Thomaschewski G, et al,. Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials. Br J Dermatol 2014; 170: 274-303.
28. Batchelor JM, Ridd MJ, Clarke T, et al,. The Eczema Priority Setting Partnership: a collaboration between patients, carers, clinicians and researchers to identify and prioritize important research questions for the treatment of eczema. Br J Dermatol 2013; 168: 577-82.
29. Leung DY, Guttman-Yassky E,. Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches. J Allergy Clin Immunol 2014; 134: 769-79.
30. Stout TE, McFarland T, Mitchell JC, et al,. Recombinant filaggrin is internalized and processed to correct filaggrin deficiency. J Invest Dermatol 2014; 134: 423-9.
31. Uitto J, Christiano AM, McLean WH, McGrath JA,. Novel molecular therapies for heritable skin disorders. J Invest Dermatol 2012; 132: 820-8.
32. Wagner JE, Ishida-Yamamoto A, McGrath JA, et al,. Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. N Engl J Med 2010; 363: 629-39.
33. Brantsch KD, Meisner C, Schönfisch B, et al,. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol 2008; 9: 713-20.
34. Marsden JR, Newton-Bishop JA, Burrows L, et al,. Revised U.K. guidelines for the management of cutaneous melanoma 2010. Br J Dermatol 2010; 163: 238-56.
35. Bath-Hextall FJ, Matin RN, Wilkinson D, Leonardi-Bee J,. Interventions for cutaneous Bowen's disease. Cochrane Database Syst Rev 2013; 6: CD007281.
36. Sullivan RJ, Flaherty KT,. Major therapeutic developments and current challenges in advanced melanoma. Br J Dermatol 2014; 170: 36-44.
37. Griewank KG, Scolyer RA, Thompson JF, et al,. Genetic alterations and personalized medicine in melanoma: progress and future prospects. J Natl Cancer Inst 2014; 106: djt435.
38. Lansbury L, Bath-Hextall F, Perkins W, et al,. Interventions for non-metastatic squamous cell carcinoma of the skin: systematic review and pooled analysis of observational studies. BMJ 2013; 347: f6153.
39. Wollina U,. Update of cetuximab for non-melanoma skin cancer. Expert Opin Biol Ther 2014; 14: 271-6.
40. Spritz RA,. Six decades of vitiligo genetics: genome-wide studies provide insights into autoimmune pathogenesis. J Invest Dermatol 2012; 132: 268-73.
41. Burden AD, Warren RB, Kleyn CE, et al,. The British Association of Dermatologists' Biologic Interventions Register (BADBIR): design, methodology and objectives. Br J Dermatol 2012; 166: 545-54.